Narnolia

Narnolia

Toll Free No: 1800-103-7212

BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE251.007.9 (+3.25 %)
PREV CLOSE ( ) 243.10
OPEN PRICE ( ) 244.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 251.00 (385)
VOLUME 184294
TODAY'S LOW / HIGH ( )242.80 252.50
52 WK LOW / HIGH ( )238.9 359.18
NSE250.957.75 (+3.19 %)
PREV CLOSE( ) 243.20
OPEN PRICE ( ) 244.20
BID PRICE (QTY) 250.95 (8)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4023193
TODAY'S LOW / HIGH( ) 242.70 252.50
52 WK LOW / HIGH ( )239 359
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 29-11 1978
Management Info
Kiran Mazumdar-Shaw - Chairman Kiran Mazumdar-Shaw - Managing Director
Registered Office

Address 20th Km,Hosur Road,Electronic City,
Bengaluru,
Karnataka-560100

Phone 91-80-2808-2808

Email investor.relations@biocon.com / co.secretary@biocon.com

Website www.biocon.com

Registrars Details
Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
19Jun Biocon shines on getting nod to sell B
Biocon is currently trading at Rs. 251.55, up by 8.45 points or 3.48% fr..
18Jun InterGlobe Aviation, KPI Global Infras
InterGlobe Aviation (IndiGo) has ordered CFM International LEAP-1A engin..
18Jun Biocon to sell BFI Business to Biocon
Biocon has received approval for sale of Branded Formulations India (BFI..
14Jun Biocon receives EU GMP Certification f
Biocon has received the Certificate of GMP compliance from EMA for its B..
14Jun Biocon informs about updates
Biocon has informed that it has received the Certificate of GMP complian..
Financials
Rs. in Millions
QTR Mar 19 ANNUAL 19
Net Profit7054927
Gross Profit 743 5521
Operating Profit 11245031
Net Sales 763928847
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
peergroup  1902.05 (0.83%)
M.Cap ( in Cr)4755.13
Eris Lifesciences (BSE)
peergroup  499.30 (2.61%)
M.Cap ( in Cr)6866.36
Procter&Gamble Healt (BSE)
peergroup  3958.10 (0.24%)
M.Cap ( in Cr)6570.20
TTK Healthcare (BSE)
peergroup  610.00 (1.40%)
M.Cap ( in Cr)861.95
Bajaj Healthcare (BSE)
peergroup  207.00 (3.50%)
M.Cap ( in Cr)285.64
Shareholding Pattern
PROMOTERS 60.67%
MUTUAL FUNDS/UTI 2.86%
NON-INSTITUTION 17.05%
FI/BANKS/INSURANCE 1.16%
GOVERNMENT 0%
FII 0%
About Biocon Ltd.

Biocon Ltd. was incorporated in the year 29-11-1978. Its today's share price is 243.1. Its current market capitalisation stands at Rs 30120 Cr. In the latest quarter, company has reported Gross Sales of Rs. 41297 Cr and Total Income of Rs.43296 Cr. The company's management includes Bobby Kanubhai Parikh, Vijay Kuchroo, Daniel M Bradbury, Ravi Mazumdar, Jeremy Levin, M Damodaran, Russel Walls, Kiran Mazumdar-Shaw, Kiran Mazumdar-Shaw, John Shaw, Arun Chandavarkar, Mary Harney.

It is listed on the BSE with a BSE Code of 532523 , NSE with an NSE Symbol of BIOCON and ISIN of INE376G01013. It's Registered office is at 20th Km,Hosur Road,Electronic CityBengaluru-560100, Karnataka. Their Registrars are ACC Ltd. It's auditors are BSR & Co LLP, SR Batliboi & Associates, SR Batliboi & Associates LLP

Directory

IPO
Narnolia Research & Advisory Narnolia Trading Platforms Narnolia Online | media Room